{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T00:07:50Z","timestamp":1767139670988,"version":"build-2238731810"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T00:00:00Z","timestamp":1742169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T00:00:00Z","timestamp":1742169600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s00417-025-06793-x","type":"journal-article","created":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T18:35:56Z","timestamp":1742236556000},"page":"1553-1564","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evolution of ophthalmological care in adult with diabetes in France between 2010 and 2022: a nationwide study"],"prefix":"10.1007","volume":"263","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4236-6196","authenticated-orcid":false,"given":"Abir","family":"Zureik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aude","family":"Couturier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9cile","family":"Delcourt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,17]]},"reference":[{"issue":"4","key":"6793_CR1","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1159\/000499541","volume":"62","author":"O Sim\u00f3-Servat","year":"2019","unstructured":"Sim\u00f3-Servat O, Hern\u00e1ndez C, Sim\u00f3 R (2019) Diabetic Retinopathy in the Context of Patients with Diabetes. Ophthalmic Res 62(4):211\u2013217. https:\/\/doi.org\/10.1159\/000499541","journal-title":"Ophthalmic Res"},{"key":"6793_CR2","doi-asserted-by":"publisher","first-page":"556","DOI":"10.2337\/dc11-1909","volume":"35","author":"JW Yau","year":"2012","unstructured":"Yau JW, Rogers SL, Kawasaki R, Lamoureux EL, Kowalski JW, Bek T (2012) Global Prevalence and Major Risk Factors of Diabetic Retinopathy. Diabetes Care 35:556\u2013564","journal-title":"Diabetes Care"},{"issue":"11","key":"6793_CR3","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1016\/j.ophtha.2021.04.027","volume":"128","author":"ZL Teo","year":"2021","unstructured":"Teo ZL, Tham Y-C, Yu M, Chee ML, Rim TH, Cheung N, Bikbov MM, Wang YX, Tang Y, Lu Y, Wong IY, Ting DSW, Tan GSW, Jonas JB, Sabanayagam C, Wong TY, Cheng C-Y (2021) Global Prevalence of Diabetic Retinopathy and Projection of Burden through 2045: Systematic Review and Meta-analysis. Ophthalmology 128(11):1580\u20131591. https:\/\/doi.org\/10.1016\/j.ophtha.2021.04.027","journal-title":"Ophthalmology"},{"issue":"1","key":"6793_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nrdp.2016.12","volume":"2","author":"TY Wong","year":"2016","unstructured":"Wong TY, Cheung CMG, Larsen M, Sharma S, Sim\u00f3 R (2016) Diabetic retinopathy. Nat Rev Dis Prim 2(1):1\u201317. https:\/\/doi.org\/10.1038\/nrdp.2016.12","journal-title":"Nat Rev Dis Prim"},{"issue":"8","key":"6793_CR5","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1111\/jdi.13480","volume":"12","author":"KY Lin","year":"2021","unstructured":"Lin KY, Hsih WH, Lin YB, Wen CY, Chang TJ (2021) Update in the epidemiology, risk factors, screening, and treatment of diabetic retinopathy. J Diabet Investig 12(8):1322\u20131325. https:\/\/doi.org\/10.1111\/jdi.13480","journal-title":"J Diabet Investig"},{"issue":"4","key":"6793_CR6","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/S2213-8587(19)30411-5","volume":"8","author":"S Vujosevic","year":"2020","unstructured":"Vujosevic S, Aldington SJ, Silva P, Hern\u00e1ndez C, Scanlon P, Peto T, Sim\u00f3 R (2020) Screening for diabetic retinopathy\u202f: New perspectives and challenges. Lancet Diabet Endocrinol 8(4):337\u2013347. https:\/\/doi.org\/10.1016\/S2213-8587(19)30411-5","journal-title":"Lancet Diabet Endocrinol"},{"issue":"10","key":"6793_CR7","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1016\/j.ophtha.2018.04.007","volume":"125","author":"TY Wong","year":"2018","unstructured":"Wong TY, Sun J, Kawasaki R, Ruamviboonsuk P, Gupta N, Lansingh VC, Maia M, Mathenge W, Moreker S, Muqit MMK, Resnikoff S, Verdaguer J, Zhao P, Ferris F, Aiello LP, Taylor HR (2018) Guidelines on Diabetic Eye Care. Ophthalmology 125(10):1608\u20131622. https:\/\/doi.org\/10.1016\/j.ophtha.2018.04.007","journal-title":"Ophthalmology"},{"issue":"6","key":"6793_CR8","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s00592-017-0974-1","volume":"54","author":"PH Scanlon","year":"2017","unstructured":"Scanlon PH (2017) The English National Screening Programme for diabetic retinopathy 2003\u20132016. Acta Diabetol 54(6):515\u2013525. https:\/\/doi.org\/10.1007\/s00592-017-0974-1","journal-title":"Acta Diabetol"},{"issue":"2","key":"6793_CR9","doi-asserted-by":"publisher","first-page":"e004015","DOI":"10.1136\/bmjopen-2013-004015","volume":"4","author":"G Liew","year":"2014","unstructured":"Liew G, Michaelides M, Bunce C (2014) A comparison of the causes of blindness certifications in England and Wales in working age adults (16\u201364 years), 1999\u20132000 with 2009\u20132010. BMJ Open 4(2):e004015. https:\/\/doi.org\/10.1136\/bmjopen-2013-004015","journal-title":"BMJ Open"},{"issue":"10","key":"6793_CR10","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1136\/bjophthalmol-2016-310002","volume":"101","author":"LZ Wang","year":"2017","unstructured":"Wang LZ, Cheung CY, Tapp RJ, Hamzah H, Tan G, Ting D, Lamoureux E, Wong TY (2017) Availability and variability in guidelines on diabetic retinopathy screening in Asian countries. Br J Ophthalmol 101(10):1352\u20131360. https:\/\/doi.org\/10.1136\/bjophthalmol-2016-310002","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"6793_CR11","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1080\/09286586.2018.1424344","volume":"25","author":"J An","year":"2018","unstructured":"An J, Niu F, Turpcu A, Rajput Y, Cheetham TC (2018) Adherence to the American Diabetes Association retinal screening guidelines for population with diabetes in the United States. Ophthalmic Epidemiol 25(3):257\u2013265. https:\/\/doi.org\/10.1080\/09286586.2018.1424344","journal-title":"Ophthalmic Epidemiol"},{"issue":"5","key":"6793_CR12","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1159\/000506136","volume":"63","author":"A Cougnard-Gr\u00e9goire","year":"2020","unstructured":"Cougnard-Gr\u00e9goire A, Korobelnik JF, Delyfer MN, Rigalleau V, Daien V, Creuzot-Garcher C, Delcourt C (2020) Trends in the use of eye care services in adults treated for diabetes between 2008 and 2017 in France: a nationwide study. Ophthalmic Res 63(5):452\u2013459","journal-title":"Ophthalmic Res"},{"key":"6793_CR13","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.diabet.2009.06.002","volume":"35","author":"C Delcourt","year":"2009","unstructured":"Delcourt C, Massin P, Rosilio M (2009) Epidemiology of diabetic retinopathy- Contrast between the expected prevalence and the frequency of reported cases in the French population. Diabetes Metab 35:431\u2013438","journal-title":"Diabetes Metab"},{"issue":"6","key":"6793_CR14","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.therap.2023.01.009","volume":"78","author":"De Germay, S., Conte, C., Micallef, J., Bouquet, E., Chouchana, L., Lafaurie, M., Pariente, A., & Pharmacoepidemiological group of the French Society of Pharmacology and Therapeutics (SFPT)","year":"2023","unstructured":"De Germay, S., Conte, C., Micallef, J., Bouquet, E., Chouchana, L., Lafaurie, M., Pariente, A., & Pharmacoepidemiological group of the French Society of Pharmacology and Therapeutics (SFPT) (2023) Performing pharmacoepidemiological studies using the French health insurance data warehouse (SNDS): How to translate guidelines into practice. Therapie 78(6):679\u2013689. https:\/\/doi.org\/10.1016\/j.therap.2023.01.009","journal-title":"Therapie"},{"issue":"8","key":"6793_CR15","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1002\/pds.4233","volume":"26","author":"J Bezin","year":"2017","unstructured":"Bezin J, Duong M, Lassalle R, Droz C, Pariente A, Blin P, Moore N (2017) The national healthcare system claims databases in France, SNIIRAM and EGB\u202f: Powerful tools for pharmacoepidemiology. Pharmacoepidemiol Drug Saf 26(8):954\u2013962. https:\/\/doi.org\/10.1002\/pds.4233","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"6793_CR16","doi-asserted-by":"publisher","first-page":"100158","DOI":"10.1016\/j.lanepe.2021.100158","volume":"8","author":"L Semenzato","year":"2021","unstructured":"Semenzato L, Botton J, Drouin J, Cuenot F, Dray-Spira R, Weill A, Zureik M (2021) Chronic diseases, health conditions and risk of COVID-19-related hospitalization and in-hospital mortality during the first wave of the epidemic in France\u202f: A cohort study of 66 million people. Lancet Regional Health - Eur 8:100158. https:\/\/doi.org\/10.1016\/j.lanepe.2021.100158","journal-title":"Lancet Regional Health - Eur"},{"key":"6793_CR17","unstructured":"Health Data Hub\u00a0(2023)\u00a0Publication de la proc\u00e9dure d\u2019acc\u00e8s simplifi\u00e9 \u00e0 l\u2019ESND, nouvel \u00e9chantillon du SNDS rempla\u00e7ant l\u2019EGB. Health Data Hub.\u00a0https:\/\/www.health-data-hub.fr\/actualites\/publication-de-la-procedure-dacces-simplifie-lesnd-nouvel-echantillon-du-snds-remplacant. Accessed 1 Sep 2024"},{"issue":"3","key":"6793_CR18","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s00038-018-1186-3","volume":"64","author":"Fuentes, S., Cosson, E., Mandereau-Bruno, L., Fagot-Campagna, A., Bernillon, P., Goldberg, M., Fosse-Edorh, S., & CONSTANCES-Diab Group","year":"2019","unstructured":"Fuentes, S., Cosson, E., Mandereau-Bruno, L., Fagot-Campagna, A., Bernillon, P., Goldberg, M., Fosse-Edorh, S., & CONSTANCES-Diab Group (2019) Identifying diabetes cases in health administrative databases\u202f: A validation study based on a large French cohort. Int J Public Health 64(3):441\u2013450. https:\/\/doi.org\/10.1007\/s00038-018-1186-3","journal-title":"Int J Public Health"},{"issue":"70\u20136","key":"6793_CR19","first-page":"58","volume":"179","author":"T Bour","year":"2014","unstructured":"Bour T (2014) La cotation des actes avec la CCAM Rappel de quelques r\u00e8gles de bonne conduite. Les Cahiers d\u2019Ophtalmologie 179(70\u20136):58","journal-title":"Les Cahiers d\u2019Ophtalmologie"},{"key":"6793_CR20","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1471-2458-9-33","volume":"9","author":"G Rey","year":"2009","unstructured":"Rey G, Jougla E, Fouillet A, H\u00e9mon D (2009) Ecological association between a deprivation index and mortality in France over the period 1997\u20132001: Variations with spatial scale, degree of urbanicity, age, gender and cause of death. BMC Publc Health 9:33. https:\/\/doi.org\/10.1186\/1471-2458-9-33","journal-title":"BMC Publc Health"},{"key":"6793_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12877-021-02568-1","volume":"21","author":"S Drusch","year":"2021","unstructured":"Drusch S, Le Tri T, Ankri J, Zureik M, Herr M (2021) Decreasing trends in potentially inappropriate medications in older people: a nationwide repeated cross-sectional study. BMC Geriatr 21:1\u201311","journal-title":"BMC Geriatr"},{"key":"6793_CR22","unstructured":"Haute Autorit\u00e9 de Sant\u00e9 (2010) D\u00e9pistage de la r\u00e9tinopathie diab\u00e9tique par lecture diff\u00e9r\u00e9e de photographies du fond d\u2019\u0153il.\u00a0https:\/\/www.has-sante.fr\/upload\/docs\/application\/pdf\/2011-03\/synthese_et_recos_depistage_de_la_rd_vf_2011-03-02_15-09-1_169.pdf. Accessed 22 Apr 2024"},{"issue":"3","key":"6793_CR23","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1136\/bjophthalmol-2020-316030","volume":"105","author":"C Chamard","year":"2021","unstructured":"Chamard C, Daien V, Erginay A, Gautier J-F, Villain M, Tadayoni R, Carriere I, Massin P (2021) Ten-year incidence and assessment of safe screening intervals for diabetic retinopathy: The OPHDIAT study. Br J Ophthalmol 105(3):432\u2013439. https:\/\/doi.org\/10.1136\/bjophthalmol-2020-316030","journal-title":"Br J Ophthalmol"},{"issue":"9","key":"6793_CR24","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1007\/s00125-022-05727-0","volume":"65","author":"J Grauslund","year":"2022","unstructured":"Grauslund J (2022) Diabetic retinopathy screening in the emerging era of artificial intelligence. Diabetologia 65(9):1415\u20131423. https:\/\/doi.org\/10.1007\/s00125-022-05727-0","journal-title":"Diabetologia"},{"issue":"9","key":"6793_CR25","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s11892-019-1189-3","volume":"19","author":"V Bellemo","year":"2019","unstructured":"Bellemo V, Lim G, Rim TH, Tan GSW, Cheung CY, Sadda S, He M, Tufail A, Lee ML, Hsu W, Ting DSW (2019) Artificial Intelligence Screening for Diabetic Retinopathy: The Real-World Emerging Application. Curr DiabRep 19(9):72. https:\/\/doi.org\/10.1007\/s11892-019-1189-3","journal-title":"Curr DiabRep"},{"issue":"3","key":"6793_CR26","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/s41433-019-0566-0","volume":"34","author":"A Grzybowski","year":"2020","unstructured":"Grzybowski A, Brona P, Lim G, Ruamviboonsuk P, Tan GSW, Abramoff M, Ting DSW (2020) Artificial intelligence for diabetic retinopathy screening: A review. Eye 34(3):451\u2013460. https:\/\/doi.org\/10.1038\/s41433-019-0566-0","journal-title":"Eye"},{"issue":"1","key":"6793_CR27","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/aos.13613","volume":"96","author":"AA Van der Heijden","year":"2018","unstructured":"Van der Heijden AA, Abramoff MD, Verbraak F, van Hecke MV, Liem A, Nijpels G (2018) Validation of automated screening for referable diabetic retinopathy with the IDx-DR device in the Hoorn Diabetes Care System. Acta Ophthalmol 96(1):63\u201368. https:\/\/doi.org\/10.1111\/aos.13613","journal-title":"Acta Ophthalmol"},{"key":"6793_CR28","doi-asserted-by":"publisher","first-page":"205520762311766","DOI":"10.1177\/20552076231176644","volume":"9","author":"L Wewetzer","year":"2023","unstructured":"Wewetzer L, Held LA, Goetz K, Steinh\u00e4user J (2023) Determinants of the implementation of artificial intelligence-based screening for diabetic retinopathy\u2014A cross-sectional study with general practitioners in Germany. Digital Health 9:20552076231176644. https:\/\/doi.org\/10.1177\/20552076231176644","journal-title":"Digital Health"},{"issue":"7","key":"6793_CR29","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1001\/jamaophthalmol.2017.1150","volume":"135","author":"PD Jani","year":"2017","unstructured":"Jani PD, Forbes L, Choudhury A, Preisser JS, Viera AJ, Garg S (2017) Evaluation of Diabetic Retinal Screening and Factors for Ophthalmology Referral in a Telemedicine Network. JAMA Ophthalmol 135(7):706\u2013714. https:\/\/doi.org\/10.1001\/jamaophthalmol.2017.1150","journal-title":"JAMA Ophthalmol"},{"issue":"5","key":"6793_CR30","first-page":"308","volume":"14","author":"A Sachdeva","year":"2012","unstructured":"Sachdeva A, Stratton IM, Unwin J, Moreton R, Scanlon PH (2012) Diabetic retinopathy screening: study to determine risk factors for non-attendance. Diabet Primary Care 14(5):308\u2013316","journal-title":"Diabet Primary Care"},{"issue":"6","key":"6793_CR31","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/j.jdiacomp.2017.02.020","volume":"31","author":"AJ Lake","year":"2017","unstructured":"Lake AJ, Browne JL, Rees G, Speight J (2017) What factors influence uptake of retinal screening among young adults with type 2 diabetes? A qualitative study informed by the theoretical domains framework. J Diabet Complications 31(6):997\u20131006. https:\/\/doi.org\/10.1016\/j.jdiacomp.2017.02.020","journal-title":"J Diabet Complications"},{"issue":"11","key":"6793_CR32","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3390\/pharmaceutics14112330","volume":"14","author":"C Creuzot-Garcher","year":"2022","unstructured":"Creuzot-Garcher C, Massin P, Srour M, Baudin F, Dot C, Nghiem-Buffet S, Girmens J-F, Collin C, Ponthieux A, Delcourt C (2022) Epidemiology of Treated Diabetes Ocular Complications in France 2008\u20132018\u2014The LANDSCAPE French Nationwide Study. Pharmaceutics 14(11):11. https:\/\/doi.org\/10.3390\/pharmaceutics14112330","journal-title":"Pharmaceutics"},{"issue":"9","key":"6793_CR33","doi-asserted-by":"publisher","first-page":"e19236","DOI":"10.1097\/MD.0000000000019236","volume":"99","author":"L Yin","year":"2020","unstructured":"Yin L, Zhang D, Ren Q, Su X, Sun Z (2020) Prevalence and risk factors of diabetic retinopathy in diabetic patients. Medicine 99(9):e19236. https:\/\/doi.org\/10.1097\/MD.0000000000019236","journal-title":"Medicine"},{"issue":"10","key":"6793_CR34","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/j.numecd.2015.07.003","volume":"25","author":"SE Baumeister","year":"2015","unstructured":"Baumeister SE, Schomerus G, Andersen RM, Tost F, Markus MRP, V\u00f6lzke H, J\u00fcrgens C (2015) Trends of barriers to eye care among adults with diagnosed diabetes in Germany, 1997\u20132012. Nutr Metab Cardiovasc Dis 25(10):906\u2013915. https:\/\/doi.org\/10.1016\/j.numecd.2015.07.003","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"11","key":"6793_CR35","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1007\/s00592-022-01946-4","volume":"59","author":"AS Thykj\u00e6r","year":"2022","unstructured":"Thykj\u00e6r AS, Andersen N, Bek T, Heegaard S, Hajari J, Laugesen CS, M\u00f6ller S, Pedersen FN, Rosengaard L, Schielke KC, Kawasaki R, H\u00f8jlund K, Rubin KH, Stokholm L, Grauslund J (2022) Attendance in a national screening program for diabetic retinopathy: A population-based study of 205,970 patients. Acta Diabetol 59(11):1493\u20131503. https:\/\/doi.org\/10.1007\/s00592-022-01946-4","journal-title":"Acta Diabetol"},{"issue":"11","key":"6793_CR36","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1007\/s00592-023-02146-4","volume":"60","author":"TPH Nissen","year":"2023","unstructured":"Nissen TPH, Vestergaard P, Vorum H, Torp-Pedersen C, Aasbjerg K (2023) A cohort follow-up study for diabetic retinopathy screening incidence in the North Denmark Region. Acta Diabetol 60(11):1581\u20131590. https:\/\/doi.org\/10.1007\/s00592-023-02146-4","journal-title":"Acta Diabetol"},{"issue":"9","key":"6793_CR37","doi-asserted-by":"publisher","first-page":"e14583","DOI":"10.1111\/dme.14583","volume":"38","author":"Cheyne, C. P., Burgess, P. I., Broadbent, D. M., Garc\u00eda-Fi\u00f1ana, M., Stratton, I. M., Criddle, T., Wang, A., Alshukri, A., Rahni, M. M., Vazquez-Arango, P., Vora, J. P., Harding, S. P., & Group, I. S","year":"2021","unstructured":"Cheyne, C. P., Burgess, P. I., Broadbent, D. M., Garc\u00eda-Fi\u00f1ana, M., Stratton, I. M., Criddle, T., Wang, A., Alshukri, A., Rahni, M. M., Vazquez-Arango, P., Vora, J. P., Harding, S. P., & Group, I. S (2021) Incidence of sight-threatening diabetic retinopathy in an established urban screening programme\u202f: An 11-year cohort study. Diabet Med 38(9):e14583. https:\/\/doi.org\/10.1111\/dme.14583","journal-title":"Diabet Med"},{"key":"6793_CR38","unstructured":"WHO (2021) Diabetic retinopathy screening: a short guide. Increase effectiveness, maximize benefits and minimize harm. https:\/\/iris.who.int\/bitstream\/handle\/10665\/336660\/9789289055321-eng.pdf?sequence=1. Accessed 22 Apr 2024"},{"issue":"13","key":"6793_CR39","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1056\/NEJMoa1414264","volume":"372","author":"The Diabetic Retinopathy Clinical Research Network","year":"2015","unstructured":"The Diabetic Retinopathy Clinical Research Network (2015) Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema. N Engl J Med 372(13):1193\u20131203. https:\/\/doi.org\/10.1056\/NEJMoa1414264","journal-title":"N Engl J Med"},{"issue":"9","key":"6793_CR40","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1001\/jamaophthalmol.2019.1963","volume":"137","author":"NM Bressler","year":"2019","unstructured":"Bressler NM, Odia I, Maguire M, Glassman AR, Jampol LM, MacCumber MW, Shah C, Rosberger D, Sun JK (2019) Association Between Change in Visual Acuity and Change in Central Subfield Thickness During Treatment of Diabetic Macular Edema in Participants Randomized to Aflibercept, Bevacizumab, or Ranibizumab. JAMA Ophthalmology 137(9):977\u2013985. https:\/\/doi.org\/10.1001\/jamaophthalmol.2019.1963","journal-title":"JAMA Ophthalmology"},{"key":"6793_CR41","unstructured":"Open Medic (2024) Open medic\u202f: base compl\u00e8te sur les d\u00e9penses de m\u00e9dicaments interr\u00e9gimes - data.gouv.fr. https:\/\/www.data.gouv.fr\/fr\/datasets\/open-medic-base-complete-sur-les-depenses-de-medicaments-interregimes\/. Accessed 10 June 2024"},{"issue":"6","key":"6793_CR42","doi-asserted-by":"publisher","first-page":"295","DOI":"10.4239\/wjd.v4.i6.295","volume":"4","author":"HA Al Dhibi","year":"2013","unstructured":"Al Dhibi HA, Arevalo JF (2013) Clinical trials on corticosteroids for diabetic macular edema. World J Diabetes 4(6):295\u2013302. https:\/\/doi.org\/10.4239\/wjd.v4.i6.295","journal-title":"World J Diabetes"},{"key":"6793_CR43","doi-asserted-by":"publisher","unstructured":"Boscia F, Veritti D, Iaculli C, Lattanzio R, Freda S, Piergentili B, & Varano M. (2024). Management of treatment-na\u00efve diabetic macular edema patients: Review of real-world clinical data. European Journal of Ophthalmology, 11206721241237069. https:\/\/doi.org\/10.1177\/11206721241237069","DOI":"10.1177\/11206721241237069"},{"issue":"4","key":"6793_CR44","doi-asserted-by":"publisher","first-page":"e548","DOI":"10.1111\/aos.15799","volume":"102","author":"CP Creuzot Garcher","year":"2024","unstructured":"Creuzot Garcher CP, Massin P, Srour M, Baudin F, Dot C, Nghiem-Buffet S, Girmens J-F, Collin C, Ponthieux A, Delcourt C (2024) Management of diabetic macular oedema in France from 2012 to 2018: The nationwide LANDSCAPE study. Acta Ophthalmol 102(4):e548\u2013e556. https:\/\/doi.org\/10.1111\/aos.15799","journal-title":"Acta Ophthalmol"},{"key":"6793_CR45","unstructured":"Weill A, Drouin J, Desplas D, Cuenot F, Dray-Spira R, Zureik M (2020) Usage des m\u00e9dicaments de ville en France durant l\u2019\u00e9pid\u00e9mie de la Covid-19 \u2013 point de situation apr\u00e8s les 8 semaines de confinement et une semaine de post-confinement (jusqu\u2019au 17 mai 2020) EPIPHARE Groupement d\u2019int\u00e9r\u00eat scientifique (GIS) ANSM-CNAM. https:\/\/www.epi-phare.fr\/rapports-detudes-et-publications\/covid-19-usage-des-medicaments-de-ville-en-france-3\/. Accessed 20 Jan 2025"},{"key":"6793_CR46","unstructured":"Weill A, Drouin J, Desplas D, Cuenot F, Dray-Spira R, Zureik M (2021) Usage des m\u00e9dicaments de ville en France durant l\u2019\u00e9pid\u00e9mie de la Covid-19 \u2013 point de situation apr\u00e8s les 8 semaines de confinement et une semaine de post-confinement (jusqu\u2019au 25 avril 2021) (2021). EPIPHARE Groupement d\u2019int\u00e9r\u00eat scientifique (GIS) ANSM-CNAM. https:\/\/www.epi-phare.fr\/rapports-detudes-et-publications\/covid-19-usage-des-medicaments-rapport-6\/. Accessed 20 Jan 2025"},{"issue":"2","key":"6793_CR47","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1001\/jamaophthalmol.2020.5594","volume":"139","author":"S Billioti de Gage","year":"2021","unstructured":"Billioti de Gage S, Drouin J, Desplas D, Cuenot F, Dray-Spira R, Weill A, Zureik M (2021) Intravitreal Anti-Vascular Endothelial Growth Factor Use in France During the Coronavirus Disease 2019 Pandemic. JAMA Ophthalmol 139(2):240\u2013242. https:\/\/doi.org\/10.1001\/jamaophthalmol.2020.5594","journal-title":"JAMA Ophthalmol"}],"updated-by":[{"DOI":"10.1007\/s00417-025-06856-z","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T00:00:00Z","timestamp":1747612800000}}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-025-06793-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-025-06793-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-025-06793-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T09:05:57Z","timestamp":1752138357000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-025-06793-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,17]]},"references-count":47,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["6793"],"URL":"https:\/\/doi.org\/10.1007\/s00417-025-06793-x","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,17]]},"assertion":[{"value":"10 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2025","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s00417-025-06856-z","URL":"https:\/\/doi.org\/10.1007\/s00417-025-06856-z","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"There was no requirement for ethical approval or data protection agency approval because of the anonymized nature of the database. This study was thus exempt from a review by an ethical committee, and written consent was not required, according to French legislation. This study conformed to the provisions of the Declaration of Helsinki in 1995 (and revised in Edinburgh 2000).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The following authors have no conflict of interest to disclose: Abir Zureik.C\u00e9cile Delcourt is consultant for Allergan, Th\u00e9a Pharma and Novartis.Aude Couturier is consultant for AbbVie, Bayer, Horus, Novartis, Roche and Zeiss.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}